BioLineRx Ltd. (BLRX) stock
BLRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 20-F on Mar 23, 2026Score 3/30
$1.15+0.03 (+2.68%)
Close on Nov 18, 2026Market cap $5.00MP/E –Yield –
BioLineRx price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
BioLineRx's price to sales ratio was 5.2× on Nov 11, 2026, against 0.2× a year earlier. Over the last 3 years it ranged from 0.2× to 15.0×, with a median of 5.2×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 5.2× | +5.0 |
| 2025 | Dec 31, 2025 | 0.2× | −2.7 |
| 2024 | Dec 31, 2024 | 2.9× | – |
See a number that looks wrong?